Order results by:
| Issue | Title | |
| Vol 12, No 6 (2020) | A new look at back pain treatment in light of the latest ESCEO guidelines | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Zolotovskaya, Yu. A. Prokofyeva | ||
| "... that the intramuscular administration of CPs (chondroitin sulfate (CS) in particular) can increase their bioavailability ..." | ||
| Vol 13, No 1 (2021) | Systematic analysis of molecular biological mechanisms for supporting connective tissue metabolism with chondroitin sulfate | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, G. I. Nechaeva, I. A. Reier, N. V. Zagorodniy | ||
| "... chondroitin sulfate (CS) and connective tissue (CT) disease. A total of 922 publications on the relationship ..." | ||
| Vol 13, No 5 (2021) | Pathobiochemical pathways of redox imbalance in the neurological long-term effects of COVID-19 and the role of chondroitin sulfate in the redox status restoration | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, A. V. Naumov | ||
| "... on the relationship between mechanisms of chondroitin sulfate and its derivatives (chondroitin sulfate glycoprotein ..." | ||
| Vol 12, No 2 (2020) | Systematic analysis of the molecular pathophysiology of tenosynovitis: promise for using chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. M. Lila, O. A. Limanova | ||
| "... The chondroprotectors glucosamine sulfate (GS) and chondroitin sulfate (CS) show a complex anti ..." | ||
| Vol 13, No 6 (2021) | Role of chondroitin sulfate in the regulation of neuroimmunoendocrine network interactions in patients with neurological symptoms in the post-covid period | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, M. Yu. Maksimova, M. N. Sharov, Yu. S. Prokofyeva | ||
| "... The review discusses the prospects for the use of chondroitin sulfate and its derivatives for new ..." | ||
| Vol 13, No 2 (2021) | Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome) | Abstract similar documents |
| M. V. Putilina, N. V. Teplova, O. A. Gromova, I. Yu. Torshin, M. Yu. Maksimova, Yu. S. Prokofieva | ||
| "... micronutrients, which include highly purified forms of chondroitin sulfate and glucosamine sulfate, which have ..." | ||
| Vol 11, No 1 (2019) | Molecular mechanisms of myoprotective action of chondroitin sulfate and glucosamine sulfate in sarcopenia | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. M. Lila, N. A. Shostak, K. V. Rudakov | ||
| "... and to justify the use of chondroitin sulfate (CS) and glucosamine sulfate (GS) in these patients. The molecular ..." | ||
| Vol 15, No 4 (2023) | Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity | Abstract similar documents |
| O. A. Shavlovskaya, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| "... 10). The new pharmaconutraceutical Chondroguard®TRIO, which contains chondroprotectors (chondroitin ..." | ||
| Vol 12, No 3 (2020) | Experience with chondroitin sulfate in the combination therapy of lower back pain | Abstract similar documents |
| O. A. Shavlovskaya, I. D. Romanov, Yu. S. Prokofyeva | ||
| "... drugs (NSAIDs). Objective: to determine the magnitude of the effect of injectable chondroitin sulfate ..." | ||
| Vol 13, No 3 (2021) | Chondroitin sulfate in osteoarthritis treatment in patients with comorbid cardiovascular diseases: hypertension, atherosclerosis, coronary heart disease | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Bokova, I. V. Sarvilina, N. I. Shavlovskiy, Yu. D. Yukhnovskaya | ||
| "... -modifying agents – symptomatic slow-acting drugs for osteoarthritis (SYSADOA), one of which is chondroitin ..." | ||
| Vol 15, No 2 (2023) | New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council | Abstract similar documents |
| Al. B. Danilov, A. M. Lila, Yo. N. Majidova, O. A. Gromova, O. N. Tkacheva, I. V. Sarvilina, A. Yu. Kochish, A. G. Nazarenko, N. V. Zagorodniy, T. B. Minasov, L. I. Alekseeva, E. A. Taskina, Yu. V. Kotovskaya, E. N. Dudinskaya, A. V. Rozanov, E. Yu. Solovieva, O. A. Shavlovskaya, M. N. Sharov, P. R. Kamchatnov, A. P. Rachin, E. R. Barantsevich, D. A. Iskra, E. Z. Yakupov, F. I. Devlikamova, A. E. Barulin, M. V. Nesterova, T. G. Sakovets, A. N. Barinov, I. N. Dolgova, N. V. Zabolotskikh, E. V. Zonova, L. A. Shchepankevich, V. A. Parfenov, A. T. Dzhurabekova, S. Z. Khakimova | ||
| "... drugs, DMOADs): chondroitin sulfate, glucosamine sulfate, undenatured type II collagen for adjuvant ..." | ||
| Vol 14, No 2 (2022) | Post-COVID pain syndrome: a review of international observations | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Bokova, N. I. Shavlovskiy | ||
| "... of pharmaceutically standardized drugs – chondroitin sulfate (CS) and glucosamine sulfate (GS) are preferred. GS ..." | ||
| Vol 13, No 4 (2021) | Toll-like receptors as a part of osteoarthritis pathophysiology: anti-inflammatory, analgesic and neuroprotective effects | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. M. Lila, L. I. Alekseeva, E. A. Taskina | ||
| "... based on standardized forms of chondroitin sulfate (CS), which have symptom-modifying and structural ..." | ||
| Vol 11, No 3 (2019) | On the neurological roles of chondroitin sulfate and glucosamine sulfate: a systematic analysis | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, V. A. Semenov, L. I. Stakhovskaya, K. V. Rudakov | ||
| "... Chondroitin sulfate (CS) and glucosamine sulfate (GS) are widely used as chondroprotectors. Data ..." | ||
| Vol 14, No 6 (2022) | On the use of chondroitin sulfate, glucosamine sulfate and undenatured type II collagen for back and limb pain and osteoarthritis | Abstract similar documents |
| O. A. Gromova, I. Y. Torshin, A. M. Lila | ||
| "... ), chondroitin sulfate (CS) and undenatured type II collagen (UC-II) have different molecular mechanisms ..." | ||
| Vol 12, No 5 (2020) | Anti-inflammatory and anti-aging effects of chondroitin sulfate | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Zolotovskaya, Yu. S. Prokofyeva | ||
| "... background. Anti-inflammatory drugs include chondroitin sulfate (CS) that, in addition to directly affecting ..." | ||
| Vol 14, No 4 (2022) | Pharmacotherapy of pain in musculoskeletal diseases: evolution and revolution of views | Abstract similar documents |
| O. A. Shavlovskaya, I. V. Sarvilina, O. A. Gromova, M. N. Sharov, I. A. Bokova, Y. S. Prokofieva, N. I. Shavlovskiy | ||
| "... and Osteoarthritis (ESCEO, 2020) – on the prescription of SYSADOA, which include chondroitin sulfate (CS ..." | ||
| Vol 9, No 3 (2017) | Molecular effects of chondroguard in osteoarthritis and herniated discs | Abstract similar documents |
| A. M. Lila, O. A. Gromova, I. Yu. Torshin, A. G. Nazarenko, A. Yu. Gogolev | ||
| "... Chondroitin sulfates (CS) are a building material for the cartilage and have anti-inflammatory ..." | ||
| Vol 15, No 6 (2023) | Admitting a patient with musculoskeletal pain following COVID-19 disease | Abstract similar documents |
| I. D. Romanov, O. A. Shavlovskaya, I. A. Bokova | ||
| "... hip joint stage I, degenerative-dystrophic changes in the lumbosacral spine, lower back pain ..." | ||
| 1 - 19 of 19 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
